Greenbrook TMS Inc

Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

Greenbrook TMS Inc. (NASDAQ:GBNH ) Q1 2023 Earnings Conference Call May 16, 2023 10:00 AM ET Company Participants Bill Leonard - President & Chief Executive Officer Erns Loubser - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets David Martin - Bloom Burton Justin Keywood - Stifel Operator Welcome to the Greenbrook TMS Inc. Fiscal Year 2023 Q1 Results Conference Call and Webcast. All lines are currently on mute to prevent any background noise.

Greenbrook TMS Inc. (GBNH) Q1 2023 Earnings Call Transcript

Greenbrook TMS (NASDAQ: GBNH ) stock is on the move Monday as the therapy center prepares to release its latest earnings report later today. Greenbrook TMS is set to release its earnings report for the first quarter of 2023 after normal trading hours today.

Why Is Greenbrook TMS (GBNH) Stock Down 9% Today?

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2023 first quarter operational and financial results after market hours on May 15, 2023. FIRST QUARTER 2023 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on May 16, 2023 to discuss the financial results for the quarter. Dial in Numbers: Toll Free North Ame.

Greenbrook TMS Announces Dates for Its First Quarter 2023 Financial Results

Greenbrook TMS Inc. (GBNH) Q4 2022 Earnings Call Transcript

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2022 (“Q4 2022”) and year-end 2022 (“Fiscal 2022”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated. FISCAL 2022 OPERATIONAL AND FINANCIAL HIGHLIGHTS Fiscal 2022 revenue increased by 32% to $69.1 million, up $16.

Greenbrook TMS Reports Fiscal 2022 Operational and Financial Results

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 fourth quarter and year end operational and financial results after market hours on April 17, 2023. FOURTH QUARTER AND YEAR END 2022 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on April 18, 2023 to discuss the financial results for the quarter.

Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2022 Financial Results

TORONTO , April 12, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") is providing this update on the status of the management cease trade order granted by the Ontario Securities Commission (the "OSC"), the Company's principal regulator in Canada, on April 5, 2023 (the "MCTO") under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").

GREENBROOK TMS PROVIDES BI-WEEKLY MCTO STATUS UPDATE

TORONTO , April 6, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") announced today that the Ontario Securities Commission (the "OSC"), the Company's principal regulator in Canada, has granted Greenbrook's previously-announced application for the imposition of a management cease trade order under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). Greenbrook made the application in connection with its default with respect to not having filed its annual report on Form 20-F for the year ended December 31, 2022 (the "Annual Report"), which includes the Company's annual consolidated financial statements as at and for the year ended December 31, 2022, the related management's discussion and analysis, the Company's annual information form, and CEO and CFO certificates relating to the audited annual financial statements, as required by National Instrument 52-109 – Certification of Disclosure in Issuers' Annual and Interim Filings (such filings, collectively, the "Required Documents") by the prescribed filing deadline in Canada of March 31, 2023.

GREENBROOK TMS ANNOUNCES ACCEPTANCE OF ITS MANAGEMENT CEASE TRADE ORDER APPLICATION

TORONTO , April 3, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that the Company has amended its amended and restated master sales agreement (the "Master Agreement") between the Company and Neuronetics, Inc. ("Neuronetics"), pursuant to which the Company and Neuronetics have agreed to convert the Company's outstanding account balance payable to Neuronetics for the supply of TMS devices and treatment sessions to the Company from Neuronetics in the amount of approximately US$5.7 million (as of December 7, 2022) (the "December Outstanding Balance"), together with Neuronetics' out-of-pocket transaction costs, into a US$6.0 million secured promissory note (the "Neuronetics Note"). The Neuronetics Note, together with the Company's recently-announced restructuring plan (the "Restructuring Plan") and US$8.25 million equity and debt financings, is expected to provide additional cash flow relief to the Company.

Greenbrook TMS Announces Update to TMS Device Supply Arrangement with Neuronetics

TORONTO , March 29, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") announced today the Company's potential delay in the filing of its annual report on Form 20-F for the year ended December 31, 2022 (the "Annual Report") beyond the prescribed filing deadline in Canada. Both management and the Company's external auditors, KPMG LLP, agreed that additional information and analysis is necessary in order to complete the preparation and audit of the Company's annual consolidated financial statements for the year ended December 31, 2022 contained in the Annual Report.

GREENBROOK TMS ANNOUNCES DELAY IN FILING 2022 ANNUAL REPORT

Greenbrook TMS announced that it has completed a non-brokered private placement of common shares of the company for aggregate gross proceeds of approximately $6.25 million.  The post Greenbrook TMS Announces $8.25 Million In Equity And Debt Financings appeared first on Pulse 2.0.

Greenbrook TMS Announces $8.25 Million In Equity And Debt Financings

TORONTO , March 24, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has (i) completed a non-brokered private placement (the "Private Placement") of common shares of the Company (the "Common Shares") for aggregate gross proceeds of approximately US$6.25 million, and (ii) entered into amendments to its credit facility (the "Credit Facility") with Madryn Asset Management, LP and affiliates thereof ("Madryn"), whereby Madryn has agreed to extend two additional tranches of debt financing to the Company in an aggregate principal amount of US$2.0 million (the "New Loan"). Private Placement Pursuant to the Private Placement, an aggregate of 11,363,635 Common Shares were issued at a price of US$0.55 per share, for aggregate gross proceeds to the Company of approximately US$6.25 million.

Greenbrook TMS Announces US$8.25 Million Equity and Debt Financings

TORONTO , March 6, 2023 /PRNewswire/ - Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), announces today that it is embarking on a comprehensive restructuring plan (the "Restructuring Plan") that aims to strengthen the Company by leveraging its scale to further reduce complexity, streamlining its operating model and driving operational efficiencies to achieve profitability. The Restructuring Plan is aimed at focusing operations to the Company's most profitable treatment centers across the United States, streamlining of patient engagement and delivery of care while reducing facility and logistical overhead.

GREENBROOK TMS ANNOUNCES RESTRUCTURING PLAN TO REDUCE COSTS, STREAMLINE OPERATIONS AND ACHIEVE PROFITABILITY

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), announces that it has applied and received approval for a voluntary delisting of its common shares (each a “Common Share”) from the Toronto Stock Exchange (the “TSX”).

Greenbrook to Voluntarily Delist From Toronto Stock Exchange

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), announces today that it has received an aggregate of US$3.0 million in additional debt financing from its existing lender, Madryn Asset Management, LP (“Madryn”), alongside Greybrook Health Inc. (“Greybrook Health”), one of the Company's existing significant shareholders to manage the company's current liquidity requirements.

Greenbrook TMS Draws an Additional US$3.0 Million in Debt Financing

TORONTO , Feb. 7, 2023 /PRNewswire/ - Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), announces today that it has received an aggregate of US$2.75 million in debt financing from its existing lender, Madryn Asset Management, LP ("Madryn"), alongside certain of the Company's existing significant shareholders and management. Madryn Debt Financing The Company announces that it has entered into an amendment to its previously-announced credit facility with Madryn (the "Credit Facility"), whereby Madryn and its affiliated entities have extended an additional tranche of debt financing  to the Company in an aggregate principal amount of US$2.0 million, which was fully-funded at closing (the "New Loan").

GREENBROOK TMS DRAWS AN ADDITIONAL US$2.75 MILLION IN DEBT FINANCING

Greenbrook TMS, Inc. (NASDAQ:GBNH ) Q3 2022 Earnings Conference Call November 9, 2022 10:00 AM ET Company Participants Bill Leonard - President & CEO Erns Loubser - CFO Conference Call Participants Noel Atkinson - Clarus Securities Operator Welcome to the Greenbrook TMS, Inc. Q3 2022 Results Conference Call and Webcast. [Operator Instructions] I would like to remind you that this call -- conference call is being recorded today and is also being webcast on the company's website at www.greenbrooktms.com under the Investors section, Events.

Greenbrook TMS, Inc. (GBNH) Q3 2022 Earnings Call Transcript

Greenbrook TMS Inc. (GBNH) delivered earnings and revenue surprises of -131.82% and 14.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Greenbrook TMS Inc. (GBNH) Reports Q3 Loss, Tops Revenue Estimates

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its third quarter 2022 (“Q3 2022”) operational and financial results.

Greenbrook TMS Reports Third Quarter Operational and Financial Results

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 third quarter operational and financial results after market hours on November 8, 2022.

Greenbrook TMS Announces Dates for Its Third Quarter 2022 Financial Results

Greenbrook TMS Inc. (NASDAQ:GBNH ) Q2 2022 Results Conference Call August 3, 2022 10:00 AM ET Company Participants Glen Akselrod - IR Bill Leonard - President and CEO Erns Loubser - CFO Conference Call Participants Noel Atkinson - Clarus Securities David Martin - Bloom Burton Justin Keywood - Stifel GMP Tania Armstrong - Canaccord Genuity Frank Takkinen - Lake Street Capital Markets Operator Good morning, ladies and gentlemen, and welcome to the TMS Second Quarter 2022 Financial Results. [Operator Instructions] I would now like to remind everyone that this call is being recorded on Wednesday, August 3, and I'll turn the conference over to Glen Akselrod.

Greenbrook TMS Inc. (GBNH) CEO Bill Leonard on Q2 2022 Results - Earnings Call Transcript

Greenbrook TMS Inc. (GBNH) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Greenbrook TMS Inc. (GBNH) Is Attractively Priced Despite Fast-paced Momentum

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its second quarter 2022 (“Q2 2022”) operational and financial results. All values in this press release are in United States dollars, unless otherwise stated. SECOND QUARTER 2022 OPERATIONAL AND FINANCIAL HIGHLIGHTS Revenue for Q2 2022 increased by 4% to a record high of $14.2 million as compared to the second quarter of 2021 (“Q2 2021”), despite a tight labor market that cau

Greenbrook TMS Reports Second Quarter Operational and Financial Results

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 second quarter operational and financial results after market hours on August 2, 2022. SECOND QUARTER 2022 CONFERENCE CALL DETAILS: Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on August 3, 2022 to discuss the financial results for the quarter. Dial in Numbers: To

Greenbrook TMS Announces Dates for Its Second Quarter 2022 Financial Results

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of its previously-announced acquisition (the “Acquisition”) of Check Five LLC, a Delaware limited liability company (doing business as “Success TMS”) (“Success TMS”). In addition, Greenbrook announces today that it and its subsidiaries have entered into a credit ag

News for Greenbrook TMS Inc Stock (GBNH)